Tabic M.B. putojošā tablete vistām
Tabic M.B. putojošā tablete vistām
Authorised
- Infectious bursal disease virus, strain M.B., Live
Product identification
Medicine name:
Tabic M.B. putojošā tablete vistām
Active substance:
- Infectious bursal disease virus, strain M.B., Live
Target species:
-
Chicken (broiler)
-
Chicken (for reproduction)
-
Chicken (layer hen)
Route of administration:
-
Intraocular use
-
In drinking water use
Product details
Active substance and strength:
-
Infectious bursal disease virus, strain M.B., Live≥ 10 2,5 EID50/tablete
Pharmaceutical form:
-
Effervescent tablet
Withdrawal period by route of administration:
-
Intraocular use
-
Chicken (broiler)
-
Meat and offal0day
-
-
Chicken (for reproduction)
-
Meat and offal0day
-
-
Chicken (layer hen)
-
Meat and offal0day
-
-
-
In drinking water use
-
Chicken (for reproduction)
-
Meat and offal0day
-
-
Chicken (layer hen)
-
Meat and offal0day
-
-
Chicken (broiler)
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD09
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Available in:
-
Latvia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Phibro Animal Health (Poland) Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Synoptis Industrial Sp. z o.o.
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/NRP/10/0031
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 18/12/2025
